Compare EDD & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EDD | AIRS |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 345.5M | 166.3M |
| IPO Year | N/A | 2021 |
| Metric | EDD | AIRS |
|---|---|---|
| Price | $5.51 | $2.13 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.75 |
| AVG Volume (30 Days) | 254.3K | ★ 769.8K |
| Earning Date | 01-01-0001 | 11-07-2025 |
| Dividend Yield | ★ 7.52% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $157,554,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.22 | $1.53 |
| 52 Week High | $4.95 | $12.00 |
| Indicator | EDD | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 49.54 | 23.47 |
| Support Level | $5.47 | $2.11 |
| Resistance Level | $5.70 | $2.36 |
| Average True Range (ATR) | 0.07 | 0.29 |
| MACD | -0.01 | 0.10 |
| Stochastic Oscillator | 16.30 | 2.84 |
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.